共查询到19条相似文献,搜索用时 155 毫秒
1.
该文旨在比较人滑膜间充质干细胞(human synovial mesenchymal stem cells,hSMSCs)与人脐带间充质干细胞(human umbilical cord mesenchymal stem cells,hUC-MSCs)的生物学性状.流式细胞仪鉴定hSMSCs和hUC-MSCs.比较两种间... 相似文献
2.
为了筛选出能够诱导hUC-MSCs成脂或成骨分化的微生物代谢物,将hUC-MSCs接种于96孔板中,并加入代谢物筛选样品,通过观察细胞形态学变化,以及油红染色、碱性磷酸酶染色鉴定hUC-MSCs的成脂、成骨分化。从446种微生物代谢物中筛选出一种具有明显诱导hUC-MSCs成脂分化的微生物代谢物。 相似文献
3.
人脐带间充质干细胞研究进展及应用前景 总被引:1,自引:0,他引:1
人脐带问充质干细胞(hUCMSC)是来源于发育早期中胚层和外胚层、存在于脐带沃顿胶和血管周围组织中的一类具有自我更新、增殖和多向分化潜能的干细胞。当前主要通过分离、扩增传代培养,然后超低温保存的方法提取保存hUCMSC。与其他来源的干细胞相比,hUCMSC具有来源广泛、可塑性强、对供者无不利影响、无伦理争论限制等优势,并且具有很强的向多组织分化的潜能,因此hUCMSC成为在组织工程、造血干细胞移植及基因治疗等研究领域具有巨大潜力的种子细胞,在临床应用方面有十分广阔的前景。 相似文献
4.
目的:探讨脐带间充质干细胞向成脂细胞方向分化的潜能,为脂肪组织工程提供一种来源丰富的干细胞来源。方法:采用胰酶和胶原酶Ⅰ型联合消化法获得脐带间充质干细胞,通过免疫细胞化学法对其表面标志物进行鉴定,化学诱导方法诱导脐带间充质干细胞向成脂细胞方向分化,倒置显微镜观察其形态变化,油红O染色对诱导后的细胞进行染色。结果:胰酶和胶原酶Ⅰ联合消化法分离的细胞贴壁生长,呈现成纤维细胞形态,免疫细胞化学显示脐带间充质干细胞表达CD29、CD44和CD105,但不表达CD31、CD34和CD105,脐带间充质干细胞在成脂诱导培养基中细胞生长速度明显减慢,细胞形态转变为肥大、扁平、含有大量脂滴的脂肪细胞,油红O染色示胞浆充满了油滴空泡。结论:脐带间充质干细胞具有向成脂细胞方向分化的潜能,为脂肪组织工程提供了一种来源丰富、免疫力低和低分化的种子细胞。 相似文献
5.
目的:探讨人骨形态发生蛋白9(bone morphogenetic proteins 9,BMP9)在体内外诱导人脐带间充质干细胞(human umbilical cord-derived mesenchymal stem cells,hUC-MSCs)成骨分化的作用研究。方法:设立Ad-BMP9处理组和Ad-GFP对照组感染hUC-MSCs,两组细胞分别于3天、5天、7天进行ALP活性检测,14天后采用免疫组织化学染色检测骨钙素(Osteocalcin,OCN)、骨桥蛋白(Osteopotin,OPN)的表达情况,21天后茜素红染色检测矿化结节的形成;然后收集不同分组hUC-MSC用于裸鼠皮下注射成骨模型的建立,4周后取出离体骨进行Micro-CT扫描和分析,并进行H&E、Masson Trichrome、Alcain Blue染色。结果:BMP9处理组的ALP活性和矿化结节形成明显高于对照组,免疫组化染色结果显示BMP9诱导组的OCN、OPG的阳性表达明显高于对照组;裸鼠皮下注射成骨模型的观察结果显示,空白对照组没有形成肉眼可见的皮下包块,仅感染Ad-BMP9的hUC-MSCs能生成异位骨,且形成的异位骨骨量明显,骨密度平均值为396.05±0.60;H&E染色结果显示BMP9诱导生成的异位骨中形成部分成熟的骨基质和骨小梁,Masson Trichrome染色结果显示BMP9明显诱导hUC-MSCs的基质矿化作用,Alcain Blue染色结果显示BMP9明显诱导hUC-MSCs的软骨内成骨作用。结论:BMP9成功诱导人脐带间充质干细胞的体内外成骨作用,为临床骨组织工程的细胞疗法提供了明确的可行性。 相似文献
6.
7.
目的:探讨人脐带间充质干细胞(hUC-MSCs)的分离提取、体外诱导分化为脂肪细胞的能力及其相关基因的表达情况。方法:取新生儿脐带经组织培养法提取后分离培养于αMEM完全培养基中,经大量纯化与扩增后,采用倒置显微镜观察其形态与细微结构;流式技术检测其细胞周期及表面标志;以含有成脂诱导剂的αMEM培养基对P3的hUC-MSCs进行培养,诱导其向脂肪细胞方向分化,对其对诱导后的细胞进行检测。应用油红"O"染色对其进行定性鉴定;应用实时定量RT-PCR对LPL、Leptin的基因含量进行测定。结果:经过组织培养法后,细胞呈贴壁生长,细胞呈梭性或旋涡状,形态不规则,多数有凸起,细胞核较大,核仁明显;第7代以前的细胞具有较强的生长活性;流式技术检测发现此类细胞高表达CD44、CD73和CD105等细胞表面标记,而几乎不表达CD34、CD45、CD31和HLA-DR。培养至第3代的细胞约72.724%的细胞处G1期、S期的细胞仅占18.069%,第7代时G1期细胞约为83.875%、S期为9.606%左右;经成脂诱导剂诱导分化后,细胞经油红"O"染色,分化为脂肪细胞的细胞着色并呈红色,实时定量RT-PCR结果显示该部分细胞表达脂肪细胞的标志性基因LPL和Leptin。结论:P7以前的hUC-MSCs具有较强的生长分化能力,可以向脂肪细胞进行分化并表达一定量的特定标志性基因。 相似文献
8.
为了研究hSCGF-α对人脐带间充质干细胞 (Human umbilical cord mesenchymal stem cells,hUCMSCs) 的作用,采用基因工程技术获得重组人干细胞生长因子-α (Recombinant human Stem Cell Growth Factor-α,rhSCGF-α)。针对SCGF基因的高GC含量,采用PCR两步法获得hSCGF-α基因,插入pET-28a(+) 载体质粒,构建重组质粒pET-28a-SCGF-α,转化大肠杆菌BL21(DE3) 获得表达菌株。低温20 ℃诱导24 h,目标重组蛋白人干细胞生长因子-α以可溶性表达为主。通过Ni2+-NTA柱纯化,获得目标重组蛋白,电泳谱带扫描分析蛋白纯度可达90%以上。以巨噬细胞/粒细胞(Granulocyte/macrophage,GM)集落形成实验鉴定重组蛋白的生物学活性,并协同重组人巨噬细胞/粒细胞集落刺激因子(Recombinant human GM-colony stimulating factor,rhGM-CSF) 研究其对人脐带间充质干细胞的影响。结果显示,纯化的重组蛋白rhSCGF-α具有生物学活性;hSCGF-α及rhGM-CSF对hUCMSCs均有刺激增殖活性,但协同作用效果最强。 相似文献
9.
该研究探讨人尿源性干细胞(human urine-derived stem cells,hUSCs)及人脐带间充质干细胞(human umbilical cord mesenchymal stem cells,hUC-MSCs)的生物学性状差异。分离培养hUSCs及hUC-MSCs,显微镜下观察细胞形态,流式细胞术检测干细胞表面标记物,锥虫蓝拒染实验及克隆形成实验检测细胞增殖能力,划痕实验及Transwell迁移实验检测细胞迁移能力,碱性磷酸酶(alkaline phosphatase,ALP)染色、茜素红染色、油红O染色及阿利新蓝染色评估多向分化潜能。hUSCs为米粒状贴壁生长细胞,hUC-MSCs为长梭形贴壁细胞,呈旋涡状排列生长,两种细胞表型分析相似,均表达多种间充质干细胞标志物,但CD24在hUC-MSCs表达阳性,而CD105在hUSCs表达阳性。hUC-MSCs的增殖及迁移能力优于hUSCs,但后者的克隆形成能力更强。hUSCs及hUCMSCs都具有成骨、成脂、成软骨分化能力,hUC-MSCs的成骨能力强而hUSCs的成脂能力强。该研究成功分离培养出增殖能力强并具有多向分化潜能的hUSCs,该细胞与hUC-MSCs相比具有相似的生物学性状,可作为再生医学自体移植的理想种子细胞来源。 相似文献
10.
人脐带间充质干细胞(HUMSCs)是一种具有高度自我更新能力和多向分化潜能的干细胞群,具有分泌特定细胞因子、诱导肿瘤细胞凋亡、适用于基因编辑、安全性好及肿瘤趋向性等特性。有较多的研究者研究HUMSCs对肿瘤的作用,试图将HUMSCs作为肿瘤治疗的新方法。就HUMSCs抗肿瘤作用的研究进展作一综述。 相似文献
11.
12.
Yueqiu Chen Han Shen Yinglong Ding You Yu Lianbo Shao Zhenya Shen 《Journal of cellular and molecular medicine》2021,25(17):8103-8114
Transplantation of stem cells is a promising, emerging treatment for cardiovascular diseases in the modern era. Mesenchymal stem cells (MSCs) derived from the umbilical cord are one of the most promising cell sources because of their capacity for differentiation into cardiomyocytes, endothelial cells and vascular smooth muscle cells in vitro/in vivo. In addition, umbilical cord-derived MSCs (UC-MSCs) secrete many effective molecules regulating apoptosis, fibrosis and neovascularization. Another important and specific characteristic of UC-MSCs is their low immunogenicity and immunomodulatory properties. However, the application of UC-MSCs still faces some challenges, such as low survivability and tissue retention in a harmful disease environment. Gene engineering and pharmacological studies have been implemented to overcome these difficulties. In this review, we summarize the differentiation ability, secretion function, immunoregulatory properties and preclinical/clinical studies of UC-MSCs, highlighting the advantages of UC-MSCs for the treatment of cardiovascular diseases. 相似文献
13.
14.
Pubin Qiu Wencong Song Zhiwei Niu Yaofu Bai Wei Li Shaohui Pan Sha Peng Jinlian Hua 《Cell biochemistry and function》2013,31(2):159-165
This study was designed to investigate the effect of platelet‐derived growth factor (PDGF) on the proliferation of human umbilical cord mesenchymal stem cells (UC‐MSCs) and further explore the mechanism of PDGF in promoting the proliferation of UC‐MSCs. The human UC‐MSCs were treated with different concentrations of PDGF, and the effects were evaluated by counting the cell number, the cell viability, the expression of PDGF receptors analyzed by RT‐PCR, and the detection of the gene expression of cell proliferation, cell cycle and pluripotency, and Brdu assay by immunofluorescent staining and Quantitative real‐time (QRT‐PCR). The results showed that PDGF could promote the proliferation of UC‐MSCs in vitro in a dose‐dependent way, and 10 to 50 ng/ml PDGF had a significant proliferation effect on UC‐MSCs; the most obvious concentration was 50 ng/ml. Significant inhibition on the proliferation of UC‐MSCs was observed when the concentration of PDGF was higher than 100 ng/ml, and all cells died when the concentration reached 200 ng/ml PDGF. The PDGF‐treated cells had stronger proliferation and antiapoptotic capacity than the control group by Brdu staining. The expression of the proliferation‐related genes C‐MYC, PCNA and TERT and cell cycle–related genes cyclin A, cyclin 1 and CDK2 were up‐regulated in PDGF medium compared with control. However, pluripotent gene OCT4 was not significantly different between cells cultured in PDGF and cells analyzed by immunofluorescence and QRT‐PCR. The PDGF could promote the proliferation of human UC‐MSCs in vitro. Copyright © 2012 John Wiley & Sons, Ltd. 相似文献
15.
单纯生物学制剂诱导人脐带间充质干细胞向胰岛素分泌细胞快速分化 总被引:1,自引:0,他引:1
为探讨用单纯生物学制剂诱导人脐带间充质干细胞(mesenchymal stem cells derived from human umbilical cord,hUC-MSCs)向胰岛素分泌细胞分化的可行性,本研究用胶原酶Ⅱ、胰蛋白酶次序消化及两步离心法从人胎儿完整脐带中分离、纯化出hUC-MSCs;用表皮生长因子、碱性成纤维生长因子、银杏提取液和高糖培养基IMDM诱导hUC-MSCs向胰岛素分泌细胞分化。在hUC-MSCs诱导前后,用倒置显微镜观察其形态变化,RT-PCR检测其胰岛相关基因的表达;双硫腙染色鉴定胰岛样细胞团(islet-like clusters,ILCs);细胞免疫荧光染色检测ILCs中PDX-1和免疫活性胰岛素(immunoreactive insulin,IRI)的表达;化学发光法检测ILCs的IRI分泌量;Western blot鉴定IRI的性质。结果显示:纯化的hUC-MSCs呈间充质干细胞特有的形态特征:长梭形,平行或螺旋形排列;在上述单纯生物学制剂的诱导下,hUC-MSCs逐渐变圆并聚集成团;在25cm2培养瓶的细胞生长面可见上百个ILCs;ILCs表达胰岛特异性基因pdx-1、insulin;ILCs呈PDX-1和IRI免疫染色阳性反应,双硫腙染色呈阳性;ILCs可分泌IRI,但多为胰岛素原(proinsulin,PI)。以上结果提示,用表皮生长因子、碱性成纤维生长因子、银杏提取液和高糖培养基IMDM可诱导hUC-MSCs快速分化为胰岛素分泌细胞,但ILCs功能不够成熟,难以产生足量真胰岛素。 相似文献
16.
The ability of MSCs (mesenchymal stem cells) to differentiate between other cell types makes these cells an attractive therapeutic tool for cell transplantation. This project was designed to improve transdifferentiation of human MSCs into liver cells using IGF-I (insulin-like growth factor 1) which, despite its important role in liver development, has not been used for in vitro hepatic differentiation. In the present study, the MSCs derived from healthy human bone marrow samples were cultured and characterized by immunophenotyping and differentiation potential into osteoblast and adipocytes. Transdifferentiation into hepatocyte-like cells was performed in the presence/absence of IGF-I in combination with predefined hepatic differentiation cocktail. To evaluate transdifferentiation, morphological features, immuno-cytochemical staining of specific biological markers and hepatic functions were assessed. Morphological assessment and evaluation of glycogen content, albumin and AFP (α-feto protein) expression as well as albumin and urea secretion revealed statistically significant difference between experimental groups compared with the control. Morphology and function (albumin secretion) of IGF-I-treated cells were significantly better than IGF-I-free experimental group. To the best of our knowledge, our study is the first to demonstrate that the combination of IGF-I with the predefined hepatic differentiation cocktail will significantly improve the morphological features of the differentiated cells and albumin secretion. 相似文献
17.
Numerous challenges remain in the successful clinical translation of cell-based therapeutic studies for skeletal tissue repair, including appropriate cell sources and viable cell delivery systems. Poly(ethylene glycol)-poly(ε-caprolactone) (PEG-PCL) amphiphilic block copolymers have been extensively explored in microspheres preparation. Due to the introduction of hydrophilic PEG segments into PCL backbones, these copolymers have shown much more potentials in carrying protein, lipophilic drugs or genes than commonly used poly (ε-caprolactone) (PCL) and poly (lactic acid). The aim of this study is to investigate the attachment and osteogenic differentiation of human placenta derived mesenchymal stem cells (PMSCs) on PEG-PCL triblock copolymers nanofiber scaffolds. Here we demonstrated that PMSCs proliferate robustly and can be effectively differentiated into osteogenic-like cells on nanofiber scaffolds. This study provides evidence for the use of nanofiber scaffolds as an ideal supporting material for in vitro PMSCs culture and an in vivo cell delivery vehicle for bone repair. 相似文献
18.
19.
Paula H Suss Luiz Guilherme A Capriglione Fabiane Barchiki Lye Miyague Danielle Jackowski Letícia Fracaro Andressa V Schittini Alexandra C Senegaglia Carmen LK Rebelatto Márcia Olandoski Alejandro Correa Paulo RS Brofman 《Experimental biology and medicine (Maywood, N.J.)》2015,240(7):969-978
The development of new therapeutic strategies is necessary to reduce the worldwide social and economic impact of cardiovascular disease, which produces high rates of morbidity and mortality. A therapeutic option that has emerged in the last decade is cell therapy. The aim of this study was to compare the effect of transplanting human umbilical cord-derived stromal cells (UCSCs), human umbilical cord blood-derived endothelial cells (UCBECs) or a combination of these two cell types for the treatment of ischemic cardiomyopathy (IC) in a Wistar rat model. IC was induced by left coronary artery ligation, and baseline echocardiography was performed seven days later. Animals with a left ventricular ejection fraction (LVEF) of ≤40% were selected for the study. On the ninth day after IC was induced, the animals were randomized into the following experimental groups: UCSCs, UCBECs, UCSCs plus UCBECs, or vehicle (control). Thirty days after treatment, an echocardiographic analysis was performed, followed by euthanasia. The animals in all of the cell therapy groups, regardless of the cell type transplanted, had less collagen deposition in their heart tissue and demonstrated a significant improvement in myocardial function after IC. Furthermore, there was a trend of increasing numbers of blood vessels in the infarcted area. The median value of LVEF increased by 7.19% to 11.77%, whereas the control group decreased by 0.24%. These results suggest that UCSCs and UCBECs are promising cells for cellular cardiomyoplasty and can be an effective therapy for improving cardiac function following IC. 相似文献